GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Visgeneer 4197.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

7.78

+5.85%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Visgeneer

Its shares trade on Taipei Exchange under the ticker 4197.TWO. It has been listed since 24 October 2013. In the fiscal year to 31 December 2025, it reported revenue of TWD 179.1m and net income of TWD 5.2m. At that date it held total assets of TWD 335.0m and shareholders' equity of TWD 199.1m.

Visgeneer, Inc. engages in the provision of biotechnology service. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2013-10-24. The firm's main products include blood glucose testers, blood glucose test strips and skin care products. The firm distributes its products in domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
24 Oct 2013

Leadership

Pay as last reported

  • Mr. Kengshuo DaiChairman of the Board, General Manager
  • Weijie ChenDeputy General Manager
  • Jiazhen ZhangHead of Finance & Accounting
  • Zongwu CaiDirector
  • Mr. Huofu DaiDirector
  • Bin HeDirector
  • Benxian ZhangDirector
  • Ching-Lung LeeIndependent Director
  • Mr. Jen-Chi LuIndependent Director
  • Mr. Shang-Wu YuIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Visgeneer Inc provides biotechnology services to its customers.
  • The firm distributes products in the domestic market.
  • Main products include blood glucose testers and strips.

Weaknesses

  • The company is headquartered in Hsinchu, Hsinchu.
  • Visgeneer Inc went IPO on 24 October 2013.
  • The sector is Health Care with limited scope.

Opportunities

  • The firm distributes products to overseas markets.
  • Skin care products offer additional revenue streams.
  • Blood glucose test strips serve a large market.

Threats

  • Competition in the Health Care sector is intense.
  • Overseas markets may face regulatory challenges.
  • Economic fluctuations affect domestic market demand.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.